US Broker Ratings

LENZ Therapeutics, Inc. (LENZ): Analyzing the Potential 481% Upside for Investors

Investors with a keen eye on the biotechnology sector might find LENZ Therapeutics, Inc. (NASDAQ: LENZ) a compelling opportunity. With its current market cap of $129.77..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Navigating Its Stable Price and Future Prospects

KalVista Pharmaceuticals, Inc. (KALV), listed on the U.S. market, stands as a notable entity in the biotechnology sector. With a market capitalization of $1.44 billion, the..

Capricor Therapeutics (CAPR) Stock Analysis: Unpacking a 186.62% Potential Upside in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology player, has captured the attention of investors with its promising pipeline and substantial potential upside. Operating in the..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring the 12% Potential Upside in the Innovative Medical Device Sector

CeriBell, Inc. (CBLL), a key player in the healthcare sector, specifically within the medical devices industry, has captured the attention of investors with its innovative approach..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a Potential 188.83% Upside in Biotech Innovation

For investors with an eye on biotech, REGENXBIO Inc. (NASDAQ: RGNX) offers a captivating opportunity driven by its innovative gene therapy solutions and significant potential upside...

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 21.43% Potential Upside in the Digital Healthcare Sector

In an era where mental health awareness is gaining prominence, Talkspace, Inc. (NASDAQ: TALK) stands at the forefront of digital behavioral healthcare. With its innovative approach..

Nutex Health Inc. (NUTX) Stock Analysis: Investor Optimism with a 32% Upside Potential

For investors in the healthcare sector, Nutex Health Inc. (NUTX) presents a compelling opportunity. This Houston-based company, with a market capitalization of $1.47 billion, is a..

Avanos Medical, Inc. (AVNS) Stock Analysis: Revenue Growth and Challenges in Focus for Healthcare Investors

For investors with an eye on the healthcare sector, Avanos Medical, Inc. (NYSE: AVNS) stands out as a significant player in the medical devices industry. With..

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 31% Potential Upside in the Healthcare Sector

As an intriguing player in the healthcare sector, STAAR Surgical Company (NASDAQ: STAA) is attracting attention with its innovative solutions and promising growth potential. Specializing in..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unveiling a 97.71% Upside Potential in Biotech Innovation

Tyra Biosciences, Inc. (TYRA), a clinical-stage biotechnology company, is captivating investors with its ambitious approach to precision medicine, particularly in targeting fibroblast growth factor receptor (FGFR)..

Geron Corporation (GERN) Stock Analysis: Exploring a 221.97% Potential Upside in the Biotech Sector

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company headquartered in Foster City, California, stands at the forefront of oncology therapeutics development. With a market capitalization of $848.06..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Explosive 57.62% Upside Potential Fuels Investor Interest

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing the attention of the investment community with its robust potential for growth and notable developments in the biotechnology sector...

Community Health Systems, Inc. (CYH) Stock Analysis: Potential 8.86% Upside Amidst Challenging Metrics

Community Health Systems, Inc. (NYSE: CYH) operates at the heart of America’s healthcare delivery, running general acute care hospitals and a variety of associated healthcare facilities...

Xencor, Inc. (XNCR) Stock Analysis: Biotech Innovator with a 25% Upside Potential

Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company, is gaining traction in the healthcare sector with its cutting-edge antibody engineering technology. Headquartered in Pasadena, California, Xencor is..

Evolus, Inc. (EOLS) Stock Analysis: Exploring an 87% Potential Upside in the Aesthetic Beauty Market

Evolus, Inc. (NASDAQ: EOLS) has been making waves in the aesthetic beauty industry with its innovative offerings, including the popular Jeuveau and Evolysse product lines. As..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Potential Upside Amid Strong Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector with its focus on pediatric medical devices, a niche yet crucial segment within the broader medical..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 42% Upside Potential for Investors

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in manufacturing and distributing MRI-compatible medical devices. With a market capitalization of $1.06 billion,..

Replimune Group, Inc. (REPL) Stock Analysis: A Potential 51.52% Upside in Biotech Innovations

Replimune Group, Inc. (NASDAQ: REPL) stands out in the biotechnology sector with its innovative approach to cancer treatment through oncolytic immunotherapies. With a market capitalization of..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Unpacking a 192% Potential Upside in the Biotech Space

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, has captured investor attention with its promising pipeline of treatments for cystic fibrosis...

Akso Health Group (AHG) Stock Analysis: Navigating Challenges in the Medical Distribution Sector

As individual investors scour the healthcare sector for promising opportunities, Akso Health Group (AHG) emerges as a complex case. Based in Qingdao, China, this company operates..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds